AMAG Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences
16:05 EDT 29 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William
Heiden, AMAG’s chief executive officer, will participate in two investor
conferences in September. The sessions will both be conducted in a
question and an...
Other Sources for this Article
AMAG Pharmaceuticals, Inc.
Amy Sullivan, 617-498-3303
More From BioPortfolio on "AMAG Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
